$QNCX
Quince Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$29.48
▲+9.14%+$2.47
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateQuince Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is QNCX up today? It is at $29.48 (+9.14%), and our scanner flagged it 3 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment QNCX spikes, and full due diligence on QNCX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $QNCX 3 times in the last 30 days. Create a free account to track $QNCX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on QNCX from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
Likely catalystIn connection with the completion of the Sale Transaction, the Company has prepared the following unaudited pro forma condensed consolidated financial information.Reported Adjustment to recognize transaction-related costs of $40 thousand incurred in connection with the closing, including legal, advisory, and other directly attributable expenses., from the latest SEC filing. Read it →The company is cleared to issue new shares on demand, but has not yet. Size not stated in the filing.
Some filings did not state a size, so these are floors.
Active shelf on file — the company can issue new shares on demand (valid ~3 years)
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on QNCX from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
QNCX last traded at $29.48, up 9.14% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Quince Therapeutics, Inc. Common Stock (QNCX) is next expected to report earnings on Wednesday, November 11, 2026, about 52 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The QNCX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged QNCX 3 times in the last 30 days.
QNCX (Quince Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $30M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge QNCX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$QNCX discussion
Sign in to ask a question or join the discussion.